We are monitoring the impact of COVID-19 on Europe Antivenom Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1503
Share on
Share on

Europe Antivenom Market Research Report – Segmented By Type, Animal and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019 - 2024)

Pulished: February, 2020
ID: 1503
Pages: 145

Europe Antivenom Market Size & Growth (2019 -2024)

The size of the Antivenom Market in Europe is expected to reach USD 0.41 billion by 2024 from USD 0.3 billion in 2019, growing at a CAGR of 5.21% during the forecast period 2019 - 2024.

Antivenom is described as the biological product that detoxifies the poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that approximately 15,000-20,000 people die with snake bites annually in Europe. To overcome poisonous effects after venomous bites the manufacturers developed a number of Antivenom products including vaccines and hyperimmune sera.

The growing involvement of research institutes to support the development of effective antivenom products, the existence of established medical care system, and the development of effective antivenom products against multiple venomous animals are driving the growth of Europe Antivenom Market.

However, stringent regulatory, high cost of the products, and limited accessibility of antivenom products are restraining the growth of Europe Antivenom Market.

This research report is segmented & sub-segmented the market into the following categories:

  • By Type: Vaccines and Hyperimmune Sera (Homologous and Heterologous)
  • By Animal: Snakes, Scorpions, Spiders and Others
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Noteworthy companies leading the Europe Antivenom Market are Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh) and Bharat Serum.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Vaccines  

                                5.1.3 Hyperimmune Sera             

                                                5.1.3.1 Homologous

                                                5.1.3.2 Heterologous

                                5.1.4 Y-o-Y Growth Analysis, By type       

                                5.1.5 Market Attractiveness Analysis, By Type     

                                5.1.6 Market Share Analysis, By Type      

                5.2 Animal                          

                                5.2.1 Introduction           

                                5.2.2 Snakes      

                                5.2.3 Scorpions

                                5.2.4 Spiders     

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Animal  

                                5.2.7 Market Attractiveness Analysis, By Animal

                                5.2.8 Market Share Analysis, By Animal 

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.2 By Animal

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.2 By Animal

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.2 By Animal

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Instituto Bioclon, S.A. de C.V.                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer AG                     

                8.3 CSL Limited                 

                8.4 Roche                           

                8.5 Merck & Co                

                8.6 Rare Disease Therapeutics, Inc.                         

                8.7 Vins Bioproducts Limited                      

                8.8 BTG Plc                         

                8.9 Incepta Vaccine Ltd                 

                8.10 Bharat Serim and Vaccines Limited (BSV)                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  2. Europe Vaccines Market By Region, From 2019 - 2024 ( USD Million )
  3. Europe Hyperimmune Sera Market By Region, From 2019 - 2024 ( USD Million )
  4. Europe Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  5. Europe Snakes Market By Region, From 2019 - 2024 ( USD Million )
  6. Europe Scorpions Market By Region, From 2019 - 2024 ( USD Million )
  7. Europe Spiders Market By Region, From 2019 - 2024 ( USD Million )
  8. Europe Others Market By Region, From 2019 - 2024 ( USD Million )
  9. U.K. Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  10. U.K. Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  11. Germany Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  12. Germany Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  13. France Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  14. France Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  15. Italy Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  16. Italy Antivenom Market By Animal, From 2019 - 2024 ( USD Million )
  17. Spain Antivenom Market By Type, From 2019 - 2024 ( USD Million )
  18. Spain Antivenom Market By Animal, From 2019 - 2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample